Kyowa Kirin adopts AI platform to accelerate R&D, enhancing drug discovery capabilities.
Impact on stocks 2
Cognizant Technology Solutions Corp Class ACognizant selected as implementation partner for Kyowa Kirin's AI R&D platform, securing a new services contract.
Theme Impact 2
Off-coverage companies 1
Benchling's AI platform chosen by Kyowa Kirin, expanding its customer base in pharma R&D.